A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy

NCT05988073 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 413

Last updated 2026-03-16

No results posted yet for this study

Summary

This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.

Conditions

  • Multifocal Motor Neuropathy

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-29
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Bulgaria
  • Canada
  • China
  • Czechia
  • Denmark
  • France
  • Germany
  • Italy
  • Japan
  • Latvia
  • Poland
  • Romania
  • Serbia
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05988073 on ClinicalTrials.gov